Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Anemia Clinical Trials
Anemia clinical trials are recruiting across 73 cities. Here are the cities with the most active studies:
About Anemia
Anemia is a condition in which the blood lacks adequate healthy red blood cells to carry sufficient oxygen to tissues. Iron deficiency is the most common cause, affecting over 1.6 billion people worldwide. Treatment depends on the cause and may include iron supplementation, B12, or treating underlying conditions.
Clinical trials are advancing new treatments for anemia. Currently, 55 studies are recruiting a combined 32,050 participants across the United States. Research is being conducted by 35 organizations including Children's Hospital Medical Center, Cincinnati, New York Blood Center, National Cancer Institute (NCI) and 32 others.
2026 Anemia Research Landscape
As of July 2026, the anemia clinical trial landscape includes 55 actively recruiting studies across 73 cities in the United States. These studies are collectively seeking 32,050 participants, with an average enrollment target of 583 per study.
Research is being led by 35 different organizations, including Children's Hospital Medical Center, Cincinnati, New York Blood Center, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Northwell Health, and 30 others. The large number of sponsors reflects significant research interest and investment in anemia treatment advancement.
Geographically, anemia trials are most concentrated in Duarte, California (9 trials); Bethesda, Maryland (9 trials); Miami, Florida (9 trials); Cincinnati, Ohio (6 trials); Stanford, California (5 trials) and 7 other cities.
Featured Anemia Studies
Highlighted recruiting studies for anemia, selected by enrollment size and research scope.
The Congenital Dyserythropoietic Anemia Registry (CDAR)
The investigators have created and maintain a comprehensive registry for patients with the diagnosis of Congenital Dyserythropoietic Anemia (CDA) in North America. The goal of this registry is to collect long-term confidential data on patients with CDA in the US, Canada, and Mexico and maintain a bio-repository of de-identified patient blood and bone marrow specimens as a tool for the investigatio...
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Cancer in Inherited Bone Marrow Failure Syndromes
Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer...
Frequently Asked Questions About Anemia Clinical Trials
Are there anemia clinical trials near me?
Yes, there are 55 anemia clinical trials currently recruiting across 73+ cities in the United States, including Duarte, California; Bethesda, Maryland; Miami, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a anemia clinical trial?
To join a anemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are anemia clinical trials free?
Yes, participation in anemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of anemia treatments are being studied?
Current anemia clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 35 research organizations.
Is it safe to participate in anemia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 13, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 13, 2026 · Data from ClinicalTrials.gov